Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | BMY | AMGN | GILD | MRNA |
| Company | Sangamo Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5200 | 44.68 | 265.72 | 65.50 | 106.18 |
| High | 0.5339 | 45.34 | 271.68 | 66.35 | 108.15 |
| Low | 0.5030 | 44.34 | 265.72 | 64.63 | 105.25 |
| Last | 0.5195 | 45.28 | 270.13 | 65.75 | 107.38 |
| Change | +0.0165 | +0.58 | +0.75 | +0.48 | +1.20 |
| % Change | +3.28% | +1.30% | +0.28% | +0.74% | +1.13% |
| Volume | 229,169 | 5,683,998 | 367,797 | 4,714,549 | 508,094 |
| 20-Day Average Volume | 1,529,678 | 12,404,349 | 2,052,786 | 6,664,471 | 2,962,271 |
| Previous Close | 0.5030 | 44.70 | 269.38 | 65.27 | 106.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5420 | 49.49 | 269.98 | 68.30 | 105.02 |
| 20-Day Raw Stochastic | 29.47% | 9.86% | 39.73% | 11.64% | 53.16% |
| 20-Day Relative Strength | 43.00% | 31.63% | 45.39% | 30.43% | 53.99% |
| Weighted Alpha | -82.09 | -33.46 | +9.41 | -23.14 | -10.45 |
| Today's Opinion | 56% Sell | 88% Sell | 72% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 56% Sell | 88% Sell | 72% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 8% Sell | 8% Buy | 40% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.40% since 04/19/24 | -7.39% since 04/19/24 | +0.36% since 04/19/24 | -1.69% since 04/19/24 | +5.55% since 04/19/24 |
| Low | 0.4600 on 04/25/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 99.30 on 04/22/24 |
| High | 0.5700 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | -12.35% since 03/26/24 | -13.77% since 03/26/24 | -4.21% since 03/26/24 | -9.36% since 03/26/24 | -0.34% since 03/26/24 |
| Low | 0.4600 on 04/25/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 97.00 on 04/03/24 |
| High | 0.6938 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +24.89% since 01/26/24 | -8.82% since 01/26/24 | -13.43% since 01/26/24 | -17.47% since 01/26/24 | +5.14% since 01/26/24 |
| Low | 0.4113 on 01/29/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 84.06 on 02/13/24 |
| High | 1.4800 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +11.70% since 10/26/23 | -14.45% since 10/26/23 | +0.07% since 10/26/23 | -16.39% since 10/26/23 | +40.88% since 10/26/23 |
| Low | 0.2911 on 11/13/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 62.55 on 11/02/23 |
| High | 1.4800 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,371 | 90,596,128 | 144,488,960 | 81,266,176 | 40,654,200 |
| Shares Outstanding, K | 207,496 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 176,230,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -257,830,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 2,040,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -60,300,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 1.39 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 03/13/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 0.00 |